A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
13h
Evolutionary comparison points to pigs as superior models for human pancreas and diabetes research
Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team ...
Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
A six-month clinical trial found that a supplement combining citrus and grape extracts, hesperidin, and chromium ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Scientists discovered that a blood molecule called CtBP2 may play a major role in how we age. It helps regulate metabolism ...
A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...
Vertex Pharmaceuticals Incorporated remains a leader in CF treatments, fueling robust cash flow and pipeline expansions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback